Neonc Technologies Holdings, Inc.
NTHI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001979414
In the last 90 days, Neonc Technologies Holdings, Inc. insiders filed 8 open-market purchases and 1 sale; 21 institutions reported holding it in 13F filings for Q2 2026, worth $14.3M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Neonc Technologies Holdings, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −6 vs. Q1 2026
- Shares held
- 3.16M
- +256.9K (+8.9%) vs. Q1 2026
- Total value
- $14.3M
- −$5.96M (−29.4%) vs. Q1 2026
- New holders
- 2
- 10 more added
- Sold out
- 8
- 4 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NTHI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $14.3M |
| Q1 2026 | 27 | $20.3M |
| Q4 2025 | 24 | $17.6M |
| Q3 2025 | 19 | $16.4M |
| Q2 2025 | 10 | $2.14M |
| Q1 2025 | 4 | $619.2K |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Neonc Technologies Holdings, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 127 | $563 | 0.00% | +127 | New |
| Barclays PLC | 453 | $2.05K | 0.00% | −7,609−94.4% | Reduced |
| Strategic Wealth Partners, Ltd. | 492 | $2.23K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,731 | $7.84K | 0.00% | +1,458+534.1% | Added |
| Wells Fargo & Company | 2,000 | $9.06K | 0.00% | +500+33.3% | Added |
| Ancora Advisors, LLC | 2,075 | $9.40K | 0.00% | 00.0% | Unchanged |
| Vanguard Global Advisers, LLC | 4,265 | $19.3K | 0.00% | 00.0% | Unchanged |
| HCR Wealth Advisors | 15,000 | $68.0K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 15,647 | $70.9K | 0.00% | −36,275−69.9% | Reduced |
| Royal Bank of Canada | 15,625 | $71.0K | 0.00% | −1,000−6.0% | Reduced |
| Marshall Wace, LLP | 21,784 | $98.7K | 0.00% | +9,206+73.2% | Added |
| Global Retirement Partners, LLC | 27,790 | $125.9K | 0.00% | +27,790 | New |
| Northern Trust Corp | 35,871 | $162.5K | 0.00% | +12,600+54.1% | Added |
| State Street Corp | 43,170 | $195.6K | 0.00% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 91,480 | $414.4K | 0.00% | +35,464+63.3% | Added |
| Geode Capital Management, LLC | 166,120 | $752.8K | 0.00% | +39,267+31.0% | Added |
| BlackRock, Inc. | 179,850 | $814.7K | 0.00% | +24,012+15.4% | Added |
| Westmount Partners, LLC | 197,178 | $893.2K | 0.20% | +153,858+355.2% | Added |
| Bank of America Corp | 224,412 | $1.02M | 0.00% | −10,984−4.7% | Reduced |
| Vanguard Capital Management LLC | 504,171 | $2.28M | 0.00% | +288,471+133.7% | Added |
| Cinctive Capital Management LP | 1,607,464 | $7.28M | 0.29% | +181,938+12.8% | Added |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −147,360−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −119,249−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −91,036−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −35,580−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −11,432−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −5,512−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,773−100.0% | Sold out |